biguanides has been researched along with Lymphoma in 3 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we demonstrate that miRNA-mediated silencing of LKB1 confers sensitivity of lymphoma cells to mitochondrial inhibition by biguanides." | 3.96 | Repression of LKB1 by ( Avizonis, D; Bridges, HR; Bridon, G; DeCamp, LM; Donayo, AO; Duchaine, TF; Gariepy, A; Izreig, S; Johnson, NA; Jones, RG; Kaymak, I; Kitchen-Goosen, SM; Laister, RC; Minden, MD; Pollak, MN; Rudoltz, MS; Sheldon, RD; Williams, KS; Yoo, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Izreig, S | 1 |
| Gariepy, A | 1 |
| Kaymak, I | 1 |
| Bridges, HR | 1 |
| Donayo, AO | 1 |
| Bridon, G | 1 |
| DeCamp, LM | 1 |
| Kitchen-Goosen, SM | 1 |
| Avizonis, D | 1 |
| Sheldon, RD | 1 |
| Laister, RC | 1 |
| Minden, MD | 1 |
| Johnson, NA | 1 |
| Duchaine, TF | 1 |
| Rudoltz, MS | 1 |
| Yoo, S | 1 |
| Pollak, MN | 1 |
| Williams, KS | 1 |
| Jones, RG | 1 |
| Maddocks, ODK | 1 |
| Athineos, D | 1 |
| Cheung, EC | 1 |
| Lee, P | 1 |
| Zhang, T | 1 |
| van den Broek, NJF | 1 |
| Mackay, GM | 1 |
| Labuschagne, CF | 1 |
| Gay, D | 1 |
| Kruiswijk, F | 1 |
| Blagih, J | 1 |
| Vincent, DF | 1 |
| Campbell, KJ | 1 |
| Ceteci, F | 1 |
| Sansom, OJ | 1 |
| Blyth, K | 1 |
| Vousden, KH | 1 |
| Spiers, AS | 1 |
| Tattersall, MH | 1 |
| Gaya, H | 1 |
3 other studies available for biguanides and Lymphoma
| Article | Year |
|---|---|
Repression of LKB1 by
Topics: AMP-Activated Protein Kinase Kinases; Animals; Antineoplastic Agents; Apoptosis; Biguanides; Drug Re | 2020 |
Modulating the therapeutic response of tumours to dietary serine and glycine starvation.
Topics: Animals; Antioxidants; Biguanides; Cell Line, Tumor; Diet; Disease Models, Animal; Female; Food Depr | 2017 |
Indications for systemic antibiotic prophylaxis in neutropenic patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Biguanides; Blood Cell Count; Carbenicillin; Cephalot | 1974 |